TREA

85902409 - NABOTA

Follow

Information

  • Trademark
  • 85902409
  • Serial Number
    85902409
  • Registration Number
    4535957
  • Filing Date
    April 12, 2013
    12 years ago
  • Registration Date
    May 27, 2014
    11 years ago
  • Transaction Date
    February 16, 2021
    4 years ago
  • Status Date
    January 14, 2021
    4 years ago
  • Published for Opposition Date
    March 11, 2014
    11 years ago
  • Location Date
    January 14, 2021
    4 years ago
  • Status Code
    711
  • Current Location
    TMEG LAW OFFICE 103
    Employee Name
    GILBERT, REBECCA L
  • Attorney Name
    John M. Kim
    Law Office Assigned Location Code
    L30
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
NABOTA
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0051: Botulinum toxin for medical use for use in the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, pelvic pain and urge type dysfunction; Pharmaceutical preparations, namely, acne medications, acne treatment preparations, adrenal hormone preparations, alcohol for topical use, allergy and allergy relief medications, analgesics, androgen preparations, anesthetics for surgical and non-surgical use, antacids, bactericides, antiarrhythmics, antibiotics, anticoagulants, anticonvulsants, antidepressants, antidiabetic preparations, antivirals, anti-cancer preparations, anti-infectives, anti-inflammatories, antipyretics, antibacterial pharmaceuticals, calcium channel blockers, beta blockers, chemical compounds for drug delivery, eye drops, eye patches for medical purposes, hair growth stimulants, vaccines, vaccine adjuvants, vaccine stabilizers, diuretics, amino acids for medical purposes; Medicines for the treatment of gastrointestinal diseases; chemical preparations for pharmaceutical purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, pelvic pain and urge type dysfunction; chemico-pharmaceutical preparations for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, pelvic pain and urge type dysfunction; drugs for medical purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, pelvic pain and urge type dysfunction; Medicines for human purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, pelvic pain and urge type dysfunction; pharmaceutical preparations for activating cellular function; Adjuvants for medical purposes; pharmaceutical preparations for central nerve treatment; pharmaceutical preparations for diagnosis; dermatological pharmaceutical products; pharmaceutical preparations for treating skin disorders; antibiotic preparations; pharmaceutical preparations for respiratory organs; pharmaceutical preparations for chemical disorder treatment
Case File Event Statements
  • 1/15/2021 - 4 years ago
    27 - NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED Type: NCS7
  • 1/14/2021 - 4 years ago
    26 - CANCELLED SECTION 7-TOTAL Type: C7..
  • 10/19/2020 - 5 years ago
    25 - REQUEST FOR SECT 7 TOTAL SURRENDER FILED Type: C7RF
  • 1/8/2021 - 4 years ago
    24 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 10/19/2020 - 5 years ago
    23 - TEAS SECTION 7 SURRENDER RECEIVED Type: ES7S
  • 10/19/2020 - 5 years ago
    22 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/19/2020 - 5 years ago
    21 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/19/2020 - 5 years ago
    20 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/19/2020 - 5 years ago
    19 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/19/2020 - 5 years ago
    18 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 5/27/2019 - 6 years ago
    17 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 5/27/2014 - 11 years ago
    16 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/11/2014 - 11 years ago
    15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/11/2014 - 11 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/19/2014 - 11 years ago
    13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/4/2014 - 11 years ago
    12 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 1/29/2014 - 11 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/28/2014 - 11 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/28/2014 - 11 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/21/2014 - 11 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 12/30/2013 - 11 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/30/2013 - 12 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/30/2013 - 12 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/30/2013 - 12 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/29/2013 - 12 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/18/2013 - 12 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 4/16/2013 - 12 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP